Blanket Purchase Agreement 36F79719D0244-36C24122A0144
- Luminex Corporation was awarded a blanket purchase agreement by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 to deliver COVID-19 diagnostic test kits. The BPA establishes a single award vehicle with a potential value of $360,000 to acquire NXTAG EXTENDED PANELS and NXTAG COVID EXTENDED PANELS. Two firm fixed price task orders were issued against the BPA for a total of $720,000 to support the agency's coronavirus response efforts. The...
- The Department of Veterans Affairs (VA) awarded a single-award Blanket Purchase Agreement (BPA) to Luminex Corporation, a foreign-owned, for-profit manufacturer of biological testing technologies, to provide polymerase chain reaction (PCR) testing services to the VA Pittsburgh Healthcare System. The contract, valued at $519,140.00, has a period of performance through June 30, 2026 and was awarded on July 1, 2023. The BPA includes two task orders, with the first order valued at $532,050.05 and...
- Luminex Corp was awarded a Multiple Award Schedule Federal Supply Schedule contract by the General Services Administration's Federal Acquisition Service with a ceiling value of $500,000 and a performance period from December 3, 2019 through December 2, 2029. The contract provides a streamlined procurement vehicle for federal agencies to acquire Luminex's comprehensive portfolio of advanced biological testing technologies, including analytical instruments, laboratory equipment, multiplex...
- The key products and services being delivered under this federal contract IDV award are in vitro diagnostic reagents, test kits, and related medical laboratory equipment and services. The prime contractor, Luminex Corporation, was awarded a Federal Supply Schedule (FSS) contract by the Department of Veterans Affairs (VA) to provide these specialized biological testing technologies and support services. Luminex's proprietary platforms, assays, and diagnostic solutions enable automated analysis of...
- The federal contract IDV award is a Blanket Purchase Agreement (BPA) issued by the Department of Veterans Affairs (VA) to Luminex Corp, a manufacturer of biological testing technologies including multiplex diagnostic solutions. The BPA has a total ceiling value of $757,790.64 and a period of performance through July 31, 2022. Under this single award BPA, Luminex Corp has received two specific call orders to date. The first, valued at $164,760.47, is for the provision of Luminex reagents to...
- The federal contract IDV award SPE2DH22D0002 was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Luminex Corporation, a foreign-owned, for-profit manufacturer of biological testing technologies based in Austin, Texas. The contract, valued at up to $48,125,000, is an Indefinite Delivery Contract without any small business set-aside designation. Luminex, serving as the prime contractor, will provide a range of specialized diagnostic products, testing platforms, maintenance...
- The Department of Veterans Affairs Veterans Health Administration awarded a blanket purchase agreement to Luminex Corporation under the Multiple Award Schedule contracting vehicle. The BPA includes two firm fixed price call orders totaling $170,918.68 to procure COVID-19 testing analyzers, supplies, and equipment. The first call order valued at $37,929.99 is for a COVID-19 analyzer to support VISN 4 pandemic response efforts through March 2022 in Pittsburgh, Pennsylvania. The second call order...
- The Department of Veterans Affairs (VA) awarded a Blanket Purchase Agreement (BPA) to Biomerieux Inc., a global leader in in vitro diagnostics, to provide reagents and E-test strips. The contract has a ceiling value of $200,000 and a period of performance through September 30, 2025. This is a single-award BPA issued under the VA's Veterans Integrated Service Network 1 (VISN 1) to support the agency's clinical diagnostics and infectious disease testing requirements across its healthcare...
- The federal contract IDV award is a Blanket Purchase Agreement (BPA) awarded by the Department of the Air Force's 711th Human Performance Wing/USAF School of Aerospace Medicine (USAFSAM) to Luminex Corporation, a foreign-owned manufacturer of advanced multiplex diagnostic solutions. The single-award BPA, with a ceiling value of $5,762,500.00, is for the procurement of LUMINEX REAGENTS to support the agency's medical testing, research, and diagnostic needs. The BPA is primarily issued under the...
- The Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 21, has awarded a single-award Indefinite Delivery Contract to Biomerieux Inc. for the provision of specialized microbiology laboratory reagents, consumable supplies, and preventative maintenance services. The $840,000 contract, which runs from October 1, 2025 to September 30, 2030, aims to support VA-owned equipment including VitekMS, Virtuo, BacT/Alert, and MYLA diagnostic systems. The contract was...
- Invitro Diagnostics, Reagents, Test (FSS-65-VII)Master GSA Schedule
- 36F79719D0244Federal Supply Schedule
- 36F79719D0244-36C24122A0144Blanket Purchase Agreement
- 4Federal Contract Awards
Luminex Corporation was awarded a blanket purchase agreement as a prime contractor to provide reagents, consumables, and diagnostic testing services to the Department of Veterans Affairs Veterans Health Administration. Under the first task order valued at $100,000, Luminex will deliver Luminex reagents to Veterans Integrated Service Network 1 in Austin, Texas from August 1, 2023 through July 31, 2024. A subsequent task order for $54,542.40 calls for reagents, consumables, and Luminex multiplexing technology to be provided to Network 1 in North Providence, Rhode Island through July 31, 2023. Both orders were placed against Luminex's General Services Administration Federal Supply Schedule contract for in vitro diagnostics, reagents, and tests. The agreements aim to support the VA's healthcare programs through specialized medical testing and diagnostic services. Luminex will serve as the prime contractor without any set-aside designations on these blanket purchase agreement calls. Under the blanket purchase agreement awarded by the Department of Veterans Affairs, Luminex Corporation provides critical diagnostic testing supplies and services without socioeconomic restrictions. The initial task order valued at one hundred thousand dollars covers delivery of reagents to a VA location in Austin, Texas for a year-long period starting in August 2023. A subsequent task order worth fifty-four thousand five hundred forty-two dollars and forty cents involves reagents, consumables, and multiplexing technology for a site in North Providence, Rhode Island ending in July 2023. Luminex performs as the prime contractor through placement against their Federal Supply Schedule contract for in vitro diagnostics, serving to advance the VA's healthcare objectives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 8/1/22 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
BPA Call 36C24122A0144-36C24125N0845 | Luminex Corp | $95.0k | 8/1/25 | 7/31/26 | 5/9/25 | |
BPA Call 36C24122A0144-36C24122N0739 | Luminex Corp | $54.5k | 8/1/22 | 7/31/23 | 12/5/23 | |
BPA Call 36C24122A0144-36C24124N0596 | Luminex Corp | $92.7k | 8/1/24 | 7/31/25 | 11/7/25 | |
BPA Call 36C24122A0144-36C24123N0982 | Luminex Corp | $89.4k | 8/1/23 | 7/31/24 | 11/13/24 |